Literature DB >> 7608488

Effect of insulin-like growth factor II on uptake of arylsulfatase A by cultured rat hepatocytes and Kupffer cells.

F Schmitz1, R Bresciani, H Hartmann, T Braulke.   

Abstract

Mannose 6-phosphate/insulin-like growth factor II receptors have been characterized in hepatocytes and Kupffer cells isolated from adult rat liver. Affinity labeling with [125I]insulin-like growth factor II revealed a protein of Mr 250,000 in both cell types. Labeling was inhibited by an antiserum against the mannose 6-phosphate/insulin-like growth factor II receptor. In Kupffer cells, [125I]insulin-like growth factor II was also cross-linked to a second protein of Mr 130,000. In both cell types, insulin-like growth factor II was 10 times more potent than insulin-like growth factor I in displacing [125I]insulin-like growth factor II from its receptor. The mannose 6-phosphate-specific uptake of [125I]arylsulfatase A via the mannose 6-phosphate/insulin-like growth factor II receptor was inhibited by insulin-like growth factor II and antibodies against the receptor, but was not affected by insulin-like growth factor I, insulin or transforming growth factor beta 1. Cell surface iodination followed by immunoprecipitation of the mannose 6-phosphate/insulin-like growth factor II receptor showed that expression of the mannose 6-phosphate/insulin-like growth factor II receptors at the plasma membrane was increased two-fold by insulin-like growth factor II. These results suggest that binding of insulin-like growth factor II to the mannose 6-phosphate/insulin-like growth factor II receptor blocks the binding and uptake of mannose 6-phosphate-containing lysosomal enzymes and may be directly involved in a co-ordinate regulation of ligand uptake from plasma into hepatocytes and Kupffer cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7608488     DOI: 10.1016/0168-8278(95)80290-8

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  3 in total

Review 1.  The IGF axis and hepatocarcinogenesis.

Authors:  J G Scharf; F Dombrowski; G Ramadori
Journal:  Mol Pathol       Date:  2001-06

2.  Comparison of five peptide vectors for improved brain delivery of the lysosomal enzyme arylsulfatase A.

Authors:  Annika Böckenhoff; Sandra Cramer; Philipp Wölte; Simeon Knieling; Claudia Wohlenberg; Volkmar Gieselmann; Hans-Joachim Galla; Ulrich Matzner
Journal:  J Neurosci       Date:  2014-02-26       Impact factor: 6.167

3.  Deep proteomic profiling unveils arylsulfatase A as a non-alcoholic steatohepatitis inducible hepatokine and regulator of glycemic control.

Authors:  Magdalene K Montgomery; Jacqueline Bayliss; Shuai Nie; William De Nardo; Stacey N Keenan; Paula M Miotto; Hamzeh Karimkhanloo; Cheng Huang; Ralf B Schittenhelm; Anthony S Don; Andrew Ryan; Nicholas A Williamson; Geraldine J Ooi; Wendy A Brown; Paul R Burton; Benjamin L Parker; Matthew J Watt
Journal:  Nat Commun       Date:  2022-03-10       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.